Skip to main content

MyBiosource Releases Guide to Gain of Function Research

MyBiosource Inc, a company based in San Diego, CA, has recently published a blog post that offers a guide to function reasearch. Gain of function research (GoFR) is that branch of scientific research with the goal of catching viruses before outbreaks and the development of various medicines including vaccines. Specifically, GoFR is a kind of medical research that examines closely the complete set of genes of a species that has been approved for experimentation. The genetics of the species is slightly modified by utilizing medicines and other drugs. The species, which is typically a mouse or ferret, is then observed closely for any changes. The impact of the slight modification in the genetic makeup of the species may be short-term or long-term. This genetic modification may change the time it would take to heal wounds, decrease symptoms when exposed to a certain illness, reproductive success, and more.

GoFR is vital because a large number of mutations of particular viruses and diseases can blend in with the body with the result that they aren’t detected by the immune system. Through GoFR, scientists are able to observe the potential side effects of a particular medicine and examine closely for symptoms that might be indicative of something more serious happening inside the body. For this reason, scientists use species that are close to human anatomy or respond in a similar manner to an illness. However, there are many ethical issues that restrict the type of animal that can be used for experimentation.

Due to contemporary concerns about animal welfare, scientific laboratories need to ensure that they only use approved animal species and create minimal harm to them. This makes it extremely difficult to finding an approved animal. Animal testing of any kind is discouraged, which is why some GoFR studies focus on plant species and artificially grown human cells to investigate the response.

One of the primary goals of GoFR is to gain better control and comprehension of the impact of certain viruses and illnesses on a particular species. Mice, chickens, ferrets, birds, bats, and other species of mammals are all used to observe responses to potential vaccines, viruses, and other diseases. Scientists scrutinize the genes of a species and change their genetic make up in a particular way, and this is used to develop vaccines that are then utilized in human trials and eventually on the public. GoFR may also be used to enhance the durability and quality of a plant species, which is essential in agriculture for supplying the food requirements of the modern population.

But there are risks of GoFR, such as biosecurity and biosafety. GoFR can result in the creation of a widespread virus, which can become a global concern especially when this is a virus that is still largely unknown. Biological weapons may also be an undesirable product of GoFR.

MyBioSource is a leading provider of research reagents for COVID-19 and other diseases, such as PCR kits, traditional and humanized antibodies, recombinant proteins, IgG/IgM serology antibody assays, and more. They can also have different types of Enzyme Linked Immunosorbent Assay (ELISA) kits for a wide variety of species and targets. These ELISA kits are utilized for detecting various types of peptides, antigens and proteins, including VEGF, various cytokines, and EGF. They also have a wide catalog of ELISA kits for investigating an array of biochemical pathways and disease states, such as oxidative stress, the insulin signaling pathway, and cancer.

They can also provide various kinds of coronavirus test kits and related items. Various multifaceted techniques are being applied to the study of COVID-19 (SARS-CoV-2) and new items are being developed at very quickly. Overall, COVID-19 and coronavirus items from MyBioSource can be grouped into a number of areas. For example, IgM/IgG ELISA Kits and Lateral Flow/Immunchromatography Products can be applied for the detection of antibodies against COVID-19. The tests may reveal that the immune system has created antibodies against the SARS-CoV-2 viral pathogen. There are also PCR Reagents for detecting the SARS-CoV-2 virus itself, in contrast to IgM/IgG ELISA Kits which only detect the presence of antibodies against the virus. One important technique is to combine reagents for detecting the virus and IgM/IgG assays are then utilized to monitor immune responses.

Those who would like to know more about gain of function research and the various research reagents and kits available can check out the MyBiosource Inc website, or contact them on the telephone or through email.


For more information about MyBiosource Inc, contact the company here:

MyBiosource Inc
Derek Iwasiuk
MyBioSource, Inc.
P.O. Box 153308
San Diego, CA 92195-3308


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.